arrow
G

Guifang Xu

anhui medical university
H指数:33
被引数:3,831

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Established nomogram based on clinicopathological characteristics, lifestyle, and comorbidities risk factors for metachronous recurrence in curative endoscopic submucosal dissection

基于临床病理特征、生活方式及合并症风险因素的异时性复发预测列线图

2025-04-140
OA
KBTBD8/RRP15 as a potential novel therapeutic target associates with lenvatinib-inhibited progression in hepatocellular carcinoma both in vitro and in vivo

KBTBD8/RRP15 作为一种潜在的新型治疗靶点,与 lenvatinib 抑制的肝细胞癌进展相关,这种关联在体外和体内均得到证实。

2024-12-110
OAAI